Journal
NEUROTHERAPEUTICS
Volume 6, Issue 2, Pages 295-299Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.nurt.2009.01.013
Keywords
Brain; disease modification; drug-refractory epilepsy; epileptogenesis; genetically-engineered cell lines; transplantation
Ask authors/readers for more resources
About 30% of patient with epilepsy do not respond to available antiepileptic drugs. In addition to seizure suppression, novel approaches are needed to prevent or alleviate epileptogenic process after various types of brain injuries. The use of cell transplants as factories to produce endogeneous anticonvulsants or as bricks to repair abnormal ictogenic and epileptogenic neuronal circuits has generated hope that cell-based therapies could become a novel therapeutic category in the treatment arsenal of epilepsy. Herein we summarize the current status and future perspectives of cell-based therapies in the treatment of epilepsy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available